These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 27432635

  • 1. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
    Thiele T, Alt-Mayer T, Greinacher A, Bux J.
    Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
    [Abstract] [Full Text] [Related]

  • 2. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE.
    Clin Lab; 2014 Nov; 60(4):S1-39. PubMed ID: 24779310
    [Abstract] [Full Text] [Related]

  • 3. Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data.
    Daurat A, Roger C, Gris J, Daurat G, Feissel M, Le Manach Y, Lefrant J, Muller L.
    Transfusion; 2016 Jun; 56(6):1295-303. PubMed ID: 26814984
    [Abstract] [Full Text] [Related]

  • 4. [Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: which one to use?].
    Lozano ML, Rivera J, Vicente V.
    Med Clin (Barc); 2012 May 05; 138(12):528-33. PubMed ID: 21807386
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.
    Xiao W, Tormey CA, Capetillo A, Maitta RW.
    Vox Sang; 2013 Nov 05; 105(4):334-40. PubMed ID: 23802769
    [Abstract] [Full Text] [Related]

  • 7. Estimating the residual risk for HIV, HCV and HBV in different types of platelet concentrates in Germany.
    an der Heiden M, Ritter S, Hamouda O, Offergeld R.
    Vox Sang; 2015 Feb 05; 108(2):123-30. PubMed ID: 25335096
    [Abstract] [Full Text] [Related]

  • 8. Microparticle content of platelet concentrates is predicted by donor microparticles and is altered by production methods and stress.
    Maurer-Spurej E, Larsen R, Labrie A, Heaton A, Chipperfield K.
    Transfus Apher Sci; 2016 Aug 05; 55(1):35-43. PubMed ID: 27470708
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Platelet concentrates, from whole blood or collected by apheresis?
    van der Meer PF.
    Transfus Apher Sci; 2013 Apr 05; 48(2):129-31. PubMed ID: 23535511
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Disparate risks and effects of pooled whole blood-derived vs. apheresis platelet production require an integral view on the blood supply.
    Zimmermann R, Blasczyk R, Zingsem J, Eckstein R, Heuft HG.
    Vox Sang; 2010 Oct 05; 99(3):295-6; author reply 297-8. PubMed ID: 20561324
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The collection of platelets by apheresis procedures.
    Simon TL.
    Transfus Med Rev; 1994 Apr 05; 8(2):132-45. PubMed ID: 8003856
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
    BioDrugs; 2003 Apr 05; 17(1):66-8. PubMed ID: 12534321
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The use of PEG-rhuMGDF in platelet apheresis.
    Kuter DJ.
    Stem Cells; 1998 Apr 05; 16 Suppl 2():231-42. PubMed ID: 11012195
    [Abstract] [Full Text] [Related]

  • 20. I am the 9%: Making the case for whole-blood platelets.
    Seheult JN, Triulzi DJ, Yazer MH.
    Transfus Med; 2016 Jun 05; 26(3):177-85. PubMed ID: 27170206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.